Appendix 3Y – Change of Director’s Interest Notice 19 June 2017 by Audrey Thomson Appendix 3Y – Change of Director’s Interest Notice
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 15 June 2017 by Audrey Thomson Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
Lynx Financial Appointed as Corporate Advisor to Advance Commercialisation Strategy in China 9 June 2017 by Audrey Thomson Lynx Financial Appointed as Corporate Advisor to Advance Commercialisation Strategy in China
Independent Research Highlights the Need for Drugs Targeting HIV-1 in Macrophages 1 May 2017 by Audrey Thomson Independent Research Highlights the Need for Drugs Targeting HIV-1 in Macrophages
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 11 April 2017 by Justine Bednorz Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
